Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.

DOI PDF 1 Citations
  • W Y Almawi
    Department of Medicine, Harvard Medical School, Boston, MA.
  • M L Lipman
    Department of Medicine, Harvard Medical School, Boston, MA.
  • A C Stevens
    Department of Medicine, Harvard Medical School, Boston, MA.
  • B Zanker
    Department of Medicine, Harvard Medical School, Boston, MA.
  • E T Hadro
    Department of Medicine, Harvard Medical School, Boston, MA.
  • T B Strom
    Department of Medicine, Harvard Medical School, Boston, MA.

Description

<jats:title>Abstract</jats:title> <jats:p>Glucocorticoids (GCS) inhibit the transcription of multiple activation-associated cytokine genes. By Northern blot analysis now we demonstrate that antiproliferative concentrations of dexamethasone and 6 alpha-methylprednisolone block mitogen-induced IL-2 gene expression in human peripheral blood mononuclear leukocytes in a concentration-dependent fashion. In addition, using a mitogen-induced proliferation assay of human peripheral blood mononuclear leukocytes, we show that GCS-mediated anti-proliferative effects are not blocked by rIL-1, rIL-2, rIL-3, rIL-4, rIL-5, rIL-6, rTNF-alpha, rTNF-beta, and rIFN-gamma, individually at 1 to 1000 U/ml, but are totally abrogated, in a concentration-dependent fashion, by the combination of rIL-1, rIL-6, and rIFN-gamma (25 to 50 U/ml for each cytokine). Thus, blockade of cytokine expression is the primary mechanism by which GCS inhibit mitogen-driven and alloantigen-induced T cell proliferation. The immunosuppressive effects of GCS are almost certainly exacted at the level of cytokine gene transcription.</jats:p>

Journal

  • The Journal of Immunology

    The Journal of Immunology 146 (10), 3523-3527, 1991-05-15

    The American Association of Immunologists

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top